Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

38,743

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

38,743 results for “efficacy”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

Evaluation of Efficacy and Safety of Sarilumab in Patients With GCA

ClinicalTrials.gov study NCT03600805. IPD Sharing: YES. Countries: 21. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

ClinicalTrials.gov study NCT04512235. IPD Sharing: YES. Countries: 19. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria

ClinicalTrials.gov study NCT04300309. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)

ClinicalTrials.gov study NCT03437278. IPD Sharing: YES. Countries: 10. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma

ClinicalTrials.gov study NCT03568461. IPD Sharing: YES. Countries: 12. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indet

ClinicalTrials.gov study NCT06097663. IPD Sharing: YES. Countries: 3. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

ClinicalTrials.gov study NCT00879658. IPD Sharing: UNDECIDED. Countries: 12. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

ClinicalTrials.gov study NCT03905525. IPD Sharing: YES. Countries: 23. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

ClinicalTrials.gov study NCT01084252. IPD Sharing: YES. Countries: 17. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site

ClinicalTrials.gov study NCT02771210. IPD Sharing: UNDECIDED. Countries: 8. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).

ClinicalTrials.gov study NCT03713619. IPD Sharing: YES. Countries: 29. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)

ClinicalTrials.gov study NCT02855164. IPD Sharing: UNDECIDED. Countries: 17. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease

ClinicalTrials.gov study NCT02060526. IPD Sharing: YES. Countries: 8. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

ClinicalTrials.gov study NCT03104413. IPD Sharing: YES. Countries: 43. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

ClinicalTrials.gov study NCT01950819. IPD Sharing: UNDECIDED. Countries: 42. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines

ClinicalTrials.gov study NCT03580369. IPD Sharing: YES. Countries: 29. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

ClinicalTrials.gov study NCT02140554. IPD Sharing: YES. Countries: 1. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis

ClinicalTrials.gov study NCT02696031. IPD Sharing: YES. Countries: 24. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET

ClinicalTrials.gov study NCT03972488. IPD Sharing: YES. Countries: 9. Publications: 3.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy of CDZ173 in Patients With APDS/PASLI

ClinicalTrials.gov study NCT02435173. IPD Sharing: YES. Countries: 9. Publications: 3.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.